“Every single person [in the team] has been handpicked. Because not just of their skill set, not just of their experience, but because of their passion for what we do and how we want to do it. And that also, I think, it allows for a really healthy work environment where we encourage debate and we encourage, you know, different opinions because that's how we get, and we find that right path to the goal that we all share.” - John Climaco
In this episode of Tactical Friday, John Climaco returns to discuss how his company pursues the mission with purpose. By being with a team fueled by passion, it becomes possible to achieve tremendous results and through establishing an environment open to debate, everyone can feel valued and heard, which are essential to business success.
John M. Climaco, Esq. (53) is the Chairman and CEO of CNS Pharmaceuticals, Inc. (Nasdaq:CNSP), a company developing novel treatments for brain and central nervous system cancers. CNSP’s lead drug, Berubicin, is an exciting discovery for the treatment of Glioblastoma Multiforme (GBM) and potentially for other CNS malignancies. Berubicin was first discovered at the MD Anderson Cancer Center, the largest cancer research institute in the world, and is an FDA-designated Orphan Drug. In 2017 CNSP acquired all data and know-how related to the successful Phase 1 trial of Berubicin from Reata Pharmaceuticals (Nasdaq:RETA), and in 2019 Mr. Climaco led the Company’s Nasdaq IPO. CNSP expects to commence its Phase 2 clinical trial of Berubicin for the treatment of GBM 2020. Mr. Climaco also currently serves on the board of directors of Moleculin Biotech, Inc. (Nasdaq:MBRX), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates.
[00:01 - 00:41] Opening Segment
[00:42 - 10:51] The Power of Passion and the Key to Business Success
[10:52 - 12:54] Closing Segment
Key Quote:
“It makes it so much easier to have money than to be broke trying to do something like this… Money isn't a bad thing. Money is a tool to make an impact.” - Zack Knight
Connect with John
Check out CNS Pharmaceuticals, Inc. (Nasdaq:CNSP), a company developing novel treatments for brain and central nervous system cancers.
Did you love the value that we are putting out in the show? LEAVE A REVIEW and tell us what you think about the episode so we can continue on putting out great content just for you! Share this episode and help someone who wants to expand their leadership capacity or click here to listen to our previous episodes.
Tactical Leadership is brought to you by Knight Protection Services. A veteran-owned and operated company, with extensive experience in risk assessment and crime prevention. Find out more by visiting
